1. Home
  2. BWXT vs EXEL Comparison

BWXT vs EXEL Comparison

Compare BWXT & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

HOLD

Current Price

$173.13

Market Cap

16.5B

Sector

N/A

ML Signal

HOLD

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$56.10

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWXT
EXEL
Founded
1867
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5B
14.0B
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
BWXT
EXEL
Price
$173.13
$56.10
Analyst Decision
Buy
Buy
Analyst Count
11
21
Target Price
$209.70
$46.50
AVG Volume (30 Days)
878.4K
2.5M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
0.52%
N/A
EPS Growth
16.61
57.95
EPS
0.99
0.79
Revenue
$1,687,738,000.00
$452,477,000.00
Revenue This Year
$20.47
$13.61
Revenue Next Year
$9.50
$13.13
P/E Ratio
$171.87
$70.29
Revenue Growth
N/A
N/A
52 Week Low
$141.55
$33.76
52 Week High
$241.82
$57.57

Technical Indicators

Market Signals
Indicator
BWXT
EXEL
Relative Strength Index (RSI) 36.11 60.64
Support Level $165.52 $40.77
Resistance Level $182.47 $57.57
Average True Range (ATR) 6.63 1.41
MACD -1.65 -0.17
Stochastic Oscillator 17.35 69.69

Price Performance

Historical Comparison
BWXT
EXEL

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: